The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC)

BACKGROUND: Trials investigating the efficacy and safety of combining molecular targeted agent (MTA) with platinum–gemcitabine (PG) in first-line treatment of advanced non-small cell lung cancer (NSCLC) have shown inconsistent findings. This meta-analysis aimed to explore whether the addition of MTA...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiaying, He, Jieyu, Yu, Miao, Li, Taishun, Luo, Li, Liu, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268042/
https://www.ncbi.nlm.nih.gov/pubmed/27977596
http://dx.doi.org/10.1097/MD.0000000000005599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268042/
https://www.ncbi.nlm.nih.gov/pubmed/27977596
http://dx.doi.org/10.1097/MD.0000000000005599

Ejemplares similares